🇺🇸 FDA
Patent

US 8021671

Pro-apoptotic bacterial vaccines to enhance cellular immune responses

granted A61KA61K2039/522A61K39/04

Quick answer

US patent 8021671 (Pro-apoptotic bacterial vaccines to enhance cellular immune responses) held by The United States of America as represented by the Department of Veteran Affairs expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Department of Veteran Affairs
Grant date
Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2039/522, A61K39/04, A61P, A61P31/04